NCT02082821
A P2X7R Single Nucleotide Mutation Promotes Chronic Allograft Vasculopathy No drug interventions Not Available Not Available completed NCT01278745
Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation prevention 2 terminated NCT02880137
Real Time Myocardial Perfusion Echocardiography for Coronary Allograft Vasculopathy diagnostic 4 completed NCT01403142
Optical Coherence Tomography (OCT) to Evaluate Cardiac Allograft Vasculopathy (CAV) in Patient's Post Heart Transplant No drug interventions Not Available Not Available completed NCT01812434
Phosphodiesterase-5 (PDE-5) Inhibition in Heart Transplant Recipients other Not Available withdrawn NCT01569334
Identification of Non Invasive Biomarkers of Immune Endothelial Injury and Repair Associated With Cardiac Allograft Vasculopathy No drug interventions Not Available Not Available unknown_status NCT01078363
Angiotensin Converting Enzyme (ACE) Inhibition and Cardiac Allograft Vasculopathy prevention Not Available completed NCT03217786
Early Post Transplant Cardiac Allograft Vasculopathy No drug interventions Not Available Not Available active_not_recruiting NCT06089486
MARINER Trial: Multiparametric Cardiac PET for CAV Surveillance After Heart Transplantation No drug interventions screening Not Available recruiting NCT03386539
Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score treatment 3 active_not_recruiting NCT01305382
Noninvasive Evaluation of Cardiac Allograft Vasculopathy No drug interventions Not Available Not Available withdrawn NCT03405831
Effect of Ivabradine on Exercise Capacity After Heart Transplantation treatment 4 unknown_status NCT01527344
Assessment of Cardiac Allograft Vasculopathy With Optical Coherence Tomography No drug interventions Not Available Not Available completed NCT01848301
Endothelial Injury and Development of Coronary Intimal Thickening After Heart Transplantation diagnostic 1 terminated NCT02777255
Severe CAV MRI in Heart Transplant Recipient No drug interventions Not Available Not Available withdrawn NCT04105803
Cardiac Mitochondrial Function After Heart Transplantation No drug interventions Not Available Not Available unknown_status NCT04226521
Extracorporeal Photopheresis and Early Cardiac Graft Vasculopathy No drug interventions prevention Not Available completed NCT03734211
Cholesterol Lowering With EVOLocumab to Prevent Cardiac Allograft Vasculopathy in De-novo Heart Transplant Recipients prevention 3 completed NCT03393793
HEart trAnsplantation Registry of piTie-Salpetriere University Hospital No drug interventions Not Available Not Available completed NCT06147271
Impact of SGLT2 Inhibitors in Heart Transplant Recipients No drug interventions prevention 2 enrolling_by_invitation NCT05756088
Determining the Association of Microvascular Disease as Assessed by PET and Graft Injury by Donor Derived Cell Free DNA No drug interventions Not Available Not Available suspended NCT02013037
The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation treatment 3 completed NCT04791852
Potential Role of Donor-derived Cell-Free DNA as a Biomarker in Cardiac Allograft Vasculopathy No drug interventions Not Available Not Available completed NCT04193306
Efficacy and Safety Of Alirocumab to Prevent Early Cardiac Allograft Vasculopathy in Recent Heart Transplant Recipients treatment 4 recruiting NCT01157949
A Study to Compare the Effectiveness of a Drug That Suppresses the Immune System Called Thymoglobulin® in Preventing the Development of a Disease That Affects the Majority of Heart Transplant Recipients Called Cardiac Allograft Vasculopathy (CAV) treatment 3 withdrawn NCT00966836
Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy prevention 3 unknown_status NCT01424917
Noninvasive Predictors of Transplant Vasculopathy No drug interventions Not Available Not Available withdrawn NCT03808324
Heart Failure After Heart Transplantation Due to Chronic Rejection No drug interventions prevention Not Available unknown_status NCT02377648
Safety and Efficacy of Everolimus - Eluting Bioresorbable Vascular Scaffold for Cardiac Allograft Vasculopathy No drug interventions treatment 4 completed NCT02798731
Physiologic Assessment of Microvascular Function in Heart Transplant Patients No drug interventions Not Available Not Available recruiting NCT05826444
Microvascular Cardiac Allograft Vasculopathy Trial No drug interventions Not Available Not Available recruiting NCT04770012
AERIAL Trial: Antiplatelet Therapy in Heart Transplantation treatment 3 recruiting NCT01305395
Strategies To Prevent Cardiac Allograft Vasculopathy Related Events in Heart Transplant Recipients prevention Not Available withdrawn NCT01186250
Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation treatment 2 completed NCT05373108
Endothelin-1 and Cardiac Allograft Vasculopathy (CAV) other 4 completed